We develop asset strategies and execute on activities to define the commercial opportunity, support and optimize the target product profile, understand the patient journey, and identify drivers and barriers that may shape the commercial success of clinical-stage programs.
270 engagements in the last 5 years
100+ pre-commercial assets supported in the last 5 years
250 conditions supported across 40 therapeutic areas
Where to Play
How to Win
We help clients move beyond high-level market sizing to understand where real opportunity exists. Our New Product Planning work integrates patient segmentation, treatment pathways, competitive dynamics, and access considerations to quantify opportunity and clarify where and how a product can win. We have supported over 100 pre-commercial assets in the last few years, with great success.
Yes. We work with teams to refine Target Product Profiles by benchmarking clinical thresholds, evaluating competitive trade-offs, and validating assumptions with key stakeholders. This ensures development and evidence strategies are grounded in what the market will ultimately value.
We map patient journeys to understand how patients are diagnosed, treated, and managed over time, and where meaningful unmet needs exist. These insights inform positioning, evidence strategy, and prioritization decisions throughout development.
Market access considerations are built into our New Product Planning approach from the start. We assess value drivers, payer expectations, and evidence requirements early so pricing and access strategies are aligned with development and commercialization decisions.
Our work is designed to be decision-ready and forward-looking. New Product Planning insights feed directly into launch strategy, forecasting, market access planning, and cross-functional alignment, helping teams transition seamlessly from early strategy to execution.